{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:29:19Z","timestamp":1792002559963,"version":"4.4.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ejphar.2026.179151","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T15:48:47Z","timestamp":1784908127000},"page":"179151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Tumor expression of CGRP confers sensitivity to growth inhibition by the anti-CGRP antibody fremanezumab"],"prefix":"10.1016","volume":"1031","author":[{"given":"Daniela","family":"Buonvicino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Pistolesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Lapucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1040-7983","authenticated-orcid":false,"given":"Alice","family":"Molli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucrezia","family":"Timotei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina","family":"Nassini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Burgalassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"De Cesaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Chiarugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejphar.2026.179151_bib1","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1523\/JNEUROSCI.2714-16.2016","article-title":"Excitatory hindbrain-forebrain communication is required for cisplatin-induced anorexia and weight loss","volume":"37","author":"Alhadeff","year":"2017","journal-title":"J. Neurosci."},{"issue":"7935","key":"10.1016\/j.ejphar.2026.179151_bib2","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41586-022-05374-w","article-title":"Nociceptor neurons affect cancer immunosurveillance","volume":"611","author":"Balood","year":"2022","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ejphar.2026.179151_bib3","doi-asserted-by":"crossref","first-page":"194","DOI":"10.2165\/00003495-198427030-00002","article-title":"Sucralfate. A review of its pharmacodynamic properties and therapeutic use in peptic ulcer disease","volume":"27","author":"Brogden","year":"1984","journal-title":"Drugs"},{"issue":"14","key":"10.1016\/j.ejphar.2026.179151_bib5","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1111\/bph.15058","article-title":"Neuroprotection induced by dexpramipexole delays disease progression in a mouse model of progressive multiple sclerosis","volume":"177","author":"Buonvicino","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179151_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100855","article-title":"SIRT1-dependent restoration of NAD+ homeostasis after increased extracellular NAD+ exposure","volume":"297","author":"Buonvicino","year":"2021","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.ejphar.2026.179151_bib6","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/nn.4574","article-title":"Cancer-induced anorexia and malaise are mediated by CGRP neurons in the parabrachial nucleus","volume":"20","author":"Campos","year":"2017","journal-title":"Nat. Neurosci."},{"issue":"7474","key":"10.1016\/j.ejphar.2026.179151_bib7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature12596","article-title":"Genetic identification of a neural circuit that suppresses appetite","volume":"503","author":"Carter","year":"2013","journal-title":"Nature"},{"issue":"10210","key":"10.1016\/j.ejphar.2026.179151_bib8","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/S0140-6736(19)32504-8","article-title":"Targeting calcitonin gene-related peptide: a new era in migraine therapy","volume":"394","author":"Charles","year":"2019","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ejphar.2026.179151_bib9","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.neuron.2018.09.032","article-title":"Parabrachial CGRP neurons establish and sustain aversive taste memories","volume":"100","author":"Chen","year":"2018","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.ejphar.2026.179151_bib10","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.ejphar.2026.179151_bib11","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41582-018-0003-1","article-title":"CGRP as the target of new migraine therapies - successful translation from bench to clinic","volume":"14","author":"Edvinsson","year":"2018","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179151_bib12","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.canlet.2012.08.018","article-title":"Angiopoietins in angiogenesis","volume":"328","author":"Fagiani","year":"2013","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.ejphar.2026.179151_bib13","first-page":"1997","article-title":"ERK\/MAPK signalling pathway and tumorigenesis","volume":"19","author":"Guo","year":"2020","journal-title":"Exp. Ther. Med."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179151_bib14","doi-asserted-by":"crossref","first-page":"5555","DOI":"10.1038\/s41467-024-49824-7","article-title":"The neurotransmitter calcitonin gene-related peptide shapes an immunosuppressive microenvironment in medullary thyroid cancer","volume":"15","author":"Hou","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2026.179151_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1529403","article-title":"Recent advances in novel tumor immunotherapy strategies based on regulating the tumor microenvironment and immune checkpoints","volume":"16","author":"Jing","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179151_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/ijms27010214","article-title":"Targeting the MAPK pathway in cancer","volume":"27","author":"Kadasah","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179151_bib17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.tips.2018.11.003","article-title":"CGRP\/CGRP receptor antibodies: potential adverse effects due to blockade of neovascularization?","volume":"40","author":"Majima","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.ejphar.2026.179151_bib18","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/bph.13790","article-title":"Dexpramipexole improves bioenergetics and outcome in experimental stroke","volume":"175","author":"Muzzi","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.ejphar.2026.179151_bib19","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.tins.2018.03.007","article-title":"The parabrachial nucleus: CGRP neurons function as a general alarm","volume":"41","author":"Palmiter","year":"2018","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ejphar.2026.179151_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177415","article-title":"The anti-CGRP mAb Fremanezumab reverts the anti-inflammatory effects of CGRP in vitro but does not alter disease evolution in a mouse model of progressive multiple sclerosis","volume":"995","author":"Pistolesi","year":"2025","journal-title":"Eur. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.ejphar.2026.179151_bib21","doi-asserted-by":"crossref","DOI":"10.1177\/03331024251367043","article-title":"Corticosteroid-dependent increased expression of CGRP and its receptor subunits within the rodent trigeminal ganglion does not prompt cephalic allodynia","volume":"45","author":"Pistolesi","year":"2025","journal-title":"Cephalalgia"},{"key":"10.1016\/j.ejphar.2026.179151_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107818","article-title":"Anti-CGRP monoclonal antibodies counteract establishment of food aversive memories and chemotherapy-induced anorexia and weight loss","volume":"217","author":"Pistolesi","year":"2025","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179151_bib23","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1038\/s41598-020-58425-5","article-title":"Innervation of papillary thyroid cancer and its association with extra-thyroidal invasion","volume":"10","author":"Rowe","year":"2020","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.ejphar.2026.179151_bib24","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1152\/physrev.00034.2013","article-title":"Calcitonin gene-related peptide: physiology and pathophysiology","volume":"94","author":"Russell","year":"2014","journal-title":"Physiol. Rev."},{"issue":"Suppl. 2","key":"10.1016\/j.ejphar.2026.179151_bib25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/head.13084","article-title":"Overview of neuropeptides: awakening the senses?","volume":"57","author":"Russo","year":"2017","journal-title":"Headache"},{"issue":"3","key":"10.1016\/j.ejphar.2026.179151_bib26","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF02740626","article-title":"Thyroid parafollicular cells. An accessible model for the study of serotonergic neurons","volume":"13","author":"Russo","year":"1996","journal-title":"Mol. Neurobiol."},{"issue":"38","key":"10.1016\/j.ejphar.2026.179151_bib27","doi-asserted-by":"crossref","first-page":"4697","DOI":"10.1038\/onc.2014.71","article-title":"SOX2 regulates self-renewal and tumorigenicity of human melanoma-initiating cells","volume":"33","author":"Santini","year":"2014","journal-title":"Oncogene"},{"issue":"36","key":"10.1016\/j.ejphar.2026.179151_bib28","doi-asserted-by":"crossref","first-page":"13550","DOI":"10.1073\/pnas.0800767105","article-title":"Neuronal system-dependent facilitation of tumor angiogenesis and tumor growth by calcitonin gene-related peptide","volume":"105","author":"Toda","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.ejphar.2026.179151_bib29","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.tips.2010.06.006","article-title":"Regulation of signal transduction by calcitonin gene-related peptide receptors","volume":"31","author":"Walker","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"issue":"5","key":"10.1016\/j.ejphar.2026.179151_bib30","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41422-025-01098-4","article-title":"Nociceptor neurons promote PDAC progression and cancer pain by interaction with cancer-associated fibroblasts and suppression of natural killer cells","volume":"35","author":"Wang","year":"2025","journal-title":"Cell Res."},{"issue":"9","key":"10.1016\/j.ejphar.2026.179151_bib31","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.trecan.2025.07.004","article-title":"CGRP-mediated neural addiction in tumor dynamic remodeling","volume":"11","author":"Xu","year":"2025","journal-title":"Trends Cancer"},{"issue":"1","key":"10.1016\/j.ejphar.2026.179151_bib32","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41392-024-01868-3","article-title":"Targeting cytokine and chemokine signaling pathways for cancer therapy","volume":"9","author":"Yi","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"12","key":"10.1016\/j.ejphar.2026.179151_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2022.10.012","article-title":"Cancer cells co-opt nociceptive nerves to thrive in nutrient-poor environments and upon nutrient-starvation therapies","volume":"34","author":"Zhang","year":"2022","journal-title":"Cell Metab."},{"issue":"8059","key":"10.1016\/j.ejphar.2026.179151_bib34","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/s41586-025-08591-1","article-title":"Nociceptive neurons promote gastric tumour progression via a CGRP-RAMP1 axis","volume":"640","author":"Zhi","year":"2025","journal-title":"Nature"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926006333?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926006333?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:14:02Z","timestamp":1786652042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926006333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":34,"alternative-id":["S0014299926006333"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179151","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor expression of CGRP confers sensitivity to growth inhibition by the anti-CGRP antibody fremanezumab","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179151","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"179151"}}